Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions.
about
Transfusion medicine problems and solutions for the pediatric hematologist/oncologistThe Influence of Clinical and Biological Factors on Transfusion-Associated Non-ABO Antigen Alloimmunization: Responders, Hyper-Responders, and Non-RespondersExtensive genomic variability of knops blood group polymorphisms is associated with sickle cell disease in AfricaA simple genotyping procedure without DNA extraction to identify rare blood donors.A Fatal Case of Immune Hyperhemolysis with Bone Marrow Necrosis in a Patient with Sickle Cell Disease.Delayed hemolytic transfusion reaction in sickle cell diseaseIron overload in sickle cell disease.Trends in blood transfusion among hospitalized children with sickle cell disease.Economic evaluation of a hypothetical screening assay for alloimmunization risk among transfused patients with sickle cell diseaseAlloimmunization and autoimmunization in transfusion dependent thalassemia major patients: Study on 319 patients.RH genotyping in a sickle cell disease patient contributing to hematopoietic stem cell transplantation donor selection and management.DNA-based methods in the immunohematology reference laboratory.Red blood cell alloimmunization in sickle cell disease: listen to your ancestors.Factors Influencing RBC Alloimmunization: Lessons Learned from Murine Models.Genetics of transfusion recipient alloimmunization: can clues from susceptibility to autoimmunity pave the way?A Genome-Wide Screen for Large-Effect Alloimmunization Susceptibility Loci among Red Blood Cell Transfusion Recipients with Sickle Cell Disease.Alloimmunization against RBC or PLT antigens is independent of TRIM21 expression in a murine modelMolecular matching for Rh and K reduces red blood cell alloimmunisation in patients with myelodysplastic syndrome.Attitudes toward Management of Sickle Cell Disease and Its Complications: A National Survey of Academic Family Physicians.Rapid clearance of transfused murine red blood cells is associated with recipient cytokine storm and enhanced alloimmunogenicity.Pathological basis of symptoms and crises in sickle cell disorder: implications for counseling and psychotherapyThe challenges of meeting the blood transfusion requirements in Sub-Saharan Africa: the need for the development of alternatives to allogenic blood.Transfusion in the absence of inflammation induces antigen-specific tolerance to murine RBCs.Alternative blood products and clinical needs in transfusion medicine2015 proceedings of the National Heart, Lung, and Blood Institute's State of the Science in Transfusion Medicine symposium.Frequency of Red Cell Alloimmunization and Autoimmunization in Thalassemia Patients: A Report from Eastern India.Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management.Regulatory T-cell status in red cell alloimmunized responder and nonresponder miceProtective effect of HLA-DQB1 alleles against alloimmunization in patients with sickle cell disease.Prevention of red cell alloimmunization by CD25 regulatory T cells in mouse models.Overview of molecular methods in immunohematology.The association of CD81 polymorphisms with alloimmunization in sickle cell diseaseHLA alloimmunization is associated with RBC antibodies in multiply transfused patients with sickle cell disease.Hyperhemolysis syndrome in sickle cell disease: case report (recurrent episode) and literature review.Cost-effectiveness of prospective red blood cell antigen matching to prevent alloimmunization among sickle cell patients.Can the interval between antibody identifications be increased for alloimmunized patients?Red blood cell alloimmunization in sickle cell disease: prevalence in 2010.Motivators and barriers to blood donation in African American college students.Genomic polymorphisms in sickle cell disease: implications for clinical diversity and treatment.Red cell exchange does not appear to increase the rate of allo- and auto-immunization in chronically transfused children with sickle cell disease.
P2860
Q26851995-51F1C7E7-9374-465F-A402-A85943D56C67Q27000807-8A2EC5B7-010E-4C35-B690-5AFC3593D37BQ28389772-3672F1F7-0968-443F-BE38-EE67B2386B58Q33421820-249410DC-6B3B-4586-952A-45D51F6BFCF8Q33440070-CB009A1F-9AFD-4B95-954A-1F42A372D9FFQ33724538-B7689FCF-795B-44C6-B822-C83E60D0F272Q33861129-927CDD07-4792-4110-86CA-07A420BDD624Q33881818-540403D1-44B1-4A1D-9950-AD7B65483D7AQ34067039-6B1E86C5-CA5E-48EF-A6B6-16F3D20A5EE6Q34073152-A719659E-D9DC-4F7B-8D19-03922FA6D482Q34282269-6F5AD8BD-4EC3-4CA3-B126-6F85608CF262Q34679079-13A7271A-6FF3-4CA7-817A-BB4D94172F23Q34792016-4E09B14E-9B3E-49F9-993E-25D8161CD875Q34792041-C6262270-B560-4E60-B146-DB642904F908Q34792059-B0F24EEB-E881-47AA-A453-33E18E0C430BQ34792068-601B57CF-D4CE-4175-ABF3-ECC2B0FF1B5DQ34960188-B289BC85-BB5F-460E-A816-D4D79CCD708BQ35049152-13BC147B-FA1A-4963-A466-C88FFD3581D9Q35156180-929479ED-2444-4B13-98A5-4950B7DD4838Q35219015-5665BD5D-77D7-4564-B633-AB26081E402DQ35567943-A99B5ADF-1BDB-47FB-B1C1-AFDAC2F528C6Q35683857-2F8830C4-BDC6-4EDA-82E2-83CDC242C987Q35776447-8F5E7D9B-DB1F-4885-864B-43AF2D8DAC1DQ35915095-71D54AE3-F9EF-4DCF-A23F-14113DE002C8Q36068943-672DFE29-9188-4FEC-B0BB-960FEE780973Q36074678-DE24DFE0-2015-4147-B28C-12B4B432BE1AQ36106307-7030BBDD-CFE5-4351-971B-B02BB2BB28E6Q36510060-E7A329FC-99D8-4EDA-9CD2-7B1DDA0EBBCFQ36563588-6DCDE544-F54A-4A7B-932C-0CE8B73597A2Q36715618-82D18119-8075-40C9-A57D-F7B8AD717908Q36861105-08D348D2-1692-4905-BC1C-B4C135C4AE9CQ36907787-C3C581B1-906E-479E-8FFD-311BEA58502EQ37044218-BBBEFF4C-EC1C-4D2D-95AF-9A4EF6A3CF82Q37121811-4FE27364-2224-40C8-A809-3AB56F826341Q37136211-84F361D0-BED5-42E4-954F-FFBF57EAE1F0Q37174870-7937FDB0-A03F-4DAA-BBAF-3BFC6DC772B1Q37394897-2E0673B1-BA47-4F43-A8B0-162358BE3A89Q37442146-D7F55FDB-022E-40BD-9799-88EFA68BA9A9Q37810126-6D597A9C-C043-4782-B11E-6A8E60A56AEEQ37836673-1D256590-830E-4619-B67F-03EA0A2806D3
P2860
Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Clinical significance of RBC a ...... nts who received transfusions.
@ast
Clinical significance of RBC a ...... nts who received transfusions.
@en
Clinical significance of RBC a ...... nts who received transfusions.
@nl
type
label
Clinical significance of RBC a ...... nts who received transfusions.
@ast
Clinical significance of RBC a ...... nts who received transfusions.
@en
Clinical significance of RBC a ...... nts who received transfusions.
@nl
prefLabel
Clinical significance of RBC a ...... nts who received transfusions.
@ast
Clinical significance of RBC a ...... nts who received transfusions.
@en
Clinical significance of RBC a ...... nts who received transfusions.
@nl
P2093
P2860
P921
P1433
P1476
Clinical significance of RBC a ...... nts who received transfusions.
@en
P2093
Banu Aygun
Carole Paley
Savitri Padmanabhan
Visalam Chandrasekaran
P2860
P356
10.1046/J.1537-2995.2002.00007.X
P577
2002-01-01T00:00:00Z